Stock & Company Details
Evolus Inc $EOLS
Price:
N/A
N/A
66M
$504M
52 Week High:
N/A
10 Day Average Volume:
N/A
-11.22
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
EOLS technical indicators
Latest Evolus Inc (EOLS) indicator readings as of 2026-10-29.
EOLS's 14-day RSI is 49.3, in neutral territory. At $7.52 it is trading 20.3% above its 200-day moving average of $6.25, and below its 50-day average of $8.00. Price sits in the middle of its Bollinger Bands ($6.99 to $7.88). ADX reads 17.9, indicating a range-bound market rather than a trend.
Overview
Evolus Inc is a performance beauty company with a customer-centric approach to delivering breakthrough products in the self-pay aesthetic market. The company's first commercial product is Jeuveau, a proprietary of 900 kilodalton, purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical products purchased by physicians and other customers that are then sold to consumers or used in procedures for aesthetic indications that are not reimbursed by any third-party payor, such as Medicaid, Medicare, or commercial insurance. It generates product revenue from the sale of Jeuveau in the United States.
Finance Bot
Ask your questions
Start by typing a question below.
